IMAGE: JNCCN AUGUST 2021 COVER CREDIT: NCCN PLYMOUTH MEETING, PA [August 26, 2021]— Among all patients with neuroendocrine tumors (NETs), the risk of dying of cancer was higher than that of dying of other causes, but mortality varies by primary tumor site, according to a new study published in the August 2021 issue of JNCCN—Journal of...